Concr CEO Irina Babina and CTO Matthew Griffiths unpack how Bayesian foundation models can excel at uncertainty management to ...

In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

Marty Makary was appointed commissioner of the Food and Drug Administration (FDA) in 2025. The prominent surgeon, medical researcher, bestselling author, and critic of the medical ...

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

Empirical Bayes is a versatile approach to “learn from a lot” in two ways: first, from a large number of variables and, second, from a potentially large amount of prior information, for example, ...

In recent years, something unexpected has been happening in artificial intelligence. Modern AI appears to be breaking a rule that statisticians have preached for nearly a century: Keep models in a ...